A citation-based method for searching scientific literature

Achim H P Krauss, Francesco Impagnatiello, Carol B Toris, David C Gale, Ganesh Prasanna, Valentina Borghi, Valerio Chiroli, Wesley K M Chong, Samantha T Carreiro, Ennio Ongini. Exp Eye Res 2011
Times Cited: 77







List of co-cited articles
938 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study.
Robert N Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini, Jason L Vittitow, Kuldev Singh, Paul L Kaufman. Br J Ophthalmol 2015
95
44

Nitric oxide (NO): an emerging target for the treatment of glaucoma.
Megan E Cavet, Jason L Vittitow, Francesco Impagnatiello, Ennio Ongini, Elena Bastia. Invest Ophthalmol Vis Sci 2014
110
37

Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
Robert N Weinreb, Baldo Scassellati Sforzolini, Jason Vittitow, Jeffrey Liebmann. Ophthalmology 2016
70
41

eNOS, a pressure-dependent regulator of intraocular pressure.
W Daniel Stamer, Yuan Lei, Alexandra Boussommier-Calleja, Darryl R Overby, C Ross Ethier. Invest Ophthalmol Vis Sci 2011
126
31


Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study.
Felipe A Medeiros, Keith R Martin, James Peace, Baldo Scassellati Sforzolini, Jason L Vittitow, Robert N Weinreb. Am J Ophthalmol 2016
57
42

Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide.
M Wiederholt, A Sturm, A Lepple-Wienhues. Invest Ophthalmol Vis Sci 1994
154
29

NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel.
William M Dismuke, Chigozirim C Mbadugha, Dorette Z Ellis. Am J Physiol Cell Physiol 2008
81
29

A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
Valentina Borghi, Elena Bastia, Massimiliano Guzzetta, Valerio Chiroli, Carol B Toris, Minerva R Batugo, Samantha T Carreiro, Wesley K M Chong, David C Gale, David J Kucera,[...]. J Ocul Pharmacol Ther 2010
61
37

Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion.
Andrea Schneemann, Berlinde G Dijkstra, Thomas J van den Berg, Willem Kamphuis, Philip F J Hoyng. Graefes Arch Clin Exp Ophthalmol 2002
59
37


Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits.
Hanna Kotikoski, Heikki Vapaatalo, Olli Oksala. Curr Eye Res 2003
67
31

Effect of nitric oxide on anterior segment physiology in monkeys.
Galen W Heyne, Julie A Kiland, Paul L Kaufman, B'Ann T Gabelt. Invest Ophthalmol Vis Sci 2013
49
42

Regulation of Endothelin-1-Induced Trabecular Meshwork Cell Contractility by Latanoprostene Bunod.
Megan E Cavet, Thomas R Vollmer, Karen L Harrington, Karl VanDerMeid, Mary E Richardson. Invest Ophthalmol Vis Sci 2015
33
63


Alterations of ocular nitric oxide synthase in human glaucoma.
J A Nathanson, M McKee. Invest Ophthalmol Vis Sci 1995
122
25

Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma.
F Galassi, G Renieri, A Sodi, F Ucci, L Vannozzi, E Masini. Br J Ophthalmol 2004
103
25

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
Anders Heijl, M Cristina Leske, Bo Bengtsson, Leslie Hyman, Boel Bengtsson, Mohamed Hussein. Arch Ophthalmol 2002
24

Endogenous regulation of human Schlemm's canal cell volume by nitric oxide signaling.
Dorette Z Ellis, Najam A Sharif, William M Dismuke. Invest Ophthalmol Vis Sci 2010
54
33


The number of people with glaucoma worldwide in 2010 and 2020.
H A Quigley, A T Broman. Br J Ophthalmol 2006
23

Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours.
John H K Liu, John R Slight, Jason L Vittitow, Baldo Scassellati Sforzolini, Robert N Weinreb. Am J Ophthalmol 2016
39
46

A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.
F Impagnatiello, V Borghi, D C Gale, M Batugo, M Guzzetta, S Brambilla, S T Carreiro, W K M Chong, G Prasanna, V Chiroli,[...]. Exp Eye Res 2011
26
65

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
M Cristina Leske, Anders Heijl, Mohamed Hussein, Bo Bengtsson, Leslie Hyman, Eugene Komaroff. Arch Ophthalmol 2003
22

Decreased nitric oxide production in primary open-angle glaucoma.
S Doganay, C Evereklioglu, Y Turkoz, H Er. Eur J Ophthalmol 2002
67
25

Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys.
J S Schuman, K Erickson, J A Nathanson. Exp Eye Res 1994
112
20

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Michael A Kass, Dale K Heuer, Eve J Higginbotham, Chris A Johnson, John L Keltner, J Philip Miller, Richard K Parrish, M Roy Wilson, Mae O Gordon. Arch Ophthalmol 2002
20

Aqueous Humor Outflow Physiology in NOS3 Knockout Mice.
Yuan Lei, Xuejin Zhang, Maomao Song, Jihong Wu, Xinghuai Sun. Invest Ophthalmol Vis Sci 2015
37
43


Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.
Yih-Chung Tham, Xiang Li, Tien Y Wong, Harry A Quigley, Tin Aung, Ching-Yu Cheng. Ophthalmology 2014
20

Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use.
Jae Hee Kang, Janey L Wiggs, Bernard A Rosner, Susan E Hankinson, Wael Abdrabou, Bao Jian Fan, Jonathan Haines, Louis R Pasquale. Invest Ophthalmol Vis Sci 2010
93
19

Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP.
Hanna Kotikoski, Päivi Alajuuma, Eeva Moilanen, Pertteli Salmenperä, Olli Oksala, Pekka Laippala, Heikki Vapaatalo. J Ocul Pharmacol Ther 2002
68
22

Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility.
W Michael Dismuke, Jin Liang, Darryl R Overby, W Daniel Stamer. Exp Eye Res 2014
59
25

The pathophysiology and treatment of glaucoma: a review.
Robert N Weinreb, Tin Aung, Felipe A Medeiros. JAMA 2014
18

Role of nitric oxide in murine conventional outflow physiology.
Jason Y H Chang, W Daniel Stamer, Jacques Bertrand, A Thomas Read, Catherine M Marando, C Ross Ethier, Darryl R Overby. Am J Physiol Cell Physiol 2015
71
19

Intraocular Pressure-Lowering Activity of NCX 470, a Novel Nitric Oxide-Donating Bimatoprost in Preclinical Models.
Francesco Impagnatiello, Carol B Toris, Minerva Batugo, Ganesh Prasanna, Valentina Borghi, Elena Bastia, Ennio Ongini, Achim H P Krauss. Invest Ophthalmol Vis Sci 2015
27
51

Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma.
Emmanuel S Buys, Yu-Chieh Ko, Clemens Alt, Sarah R Hayton, Alexander Jones, Laurel T Tainsh, Ruiyi Ren, Andrea Giani, Maeva Clerté, Emma Abernathy,[...]. PLoS One 2013
45
26

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.
David F Garway-Heath, David P Crabb, Catey Bunce, Gerassimos Lascaratos, Francesca Amalfitano, Nitin Anand, Augusto Azuara-Blanco, Rupert R Bourne, David C Broadway, Ian A Cunliffe,[...]. Lancet 2015
351
15



Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings.
Robert N Weinreb, Jeffrey M Liebmann, Keith R Martin, Paul L Kaufman, Jason L Vittitow. J Glaucoma 2018
37
32


Current understanding of conventional outflow dysfunction in glaucoma.
W Daniel Stamer, Ted S Acott. Curr Opin Ophthalmol 2012
196
14

Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.
Emmanuel S Buys, Lincoln R Potter, Louis R Pasquale, Bruce R Ksander. Front Mol Neurosci 2014
34
32

Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension.
Robert D Williams, Gary D Novack, Thomas van Haarlem, Casey Kopczynski. Am J Ophthalmol 2011
102
12

Primary open-angle glaucoma.
Robert N Weinreb, Peng Tee Khaw. Lancet 2004
12

Novel ocular antihypertensive compounds in clinical trials.
June Chen, Stephen A Runyan, Michael R Robinson. Clin Ophthalmol 2011
78
12

A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology.
Francesca Fabrizi, Francesco Mincione, Teresa Somma, Gabriele Scozzafava, Fernando Galassi, Emanuela Masini, Francesco Impagnatiello, Claudiu T Supuran. J Enzyme Inhib Med Chem 2012
134
12

Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits.
Masahiro Orihashi, Yuichiro Shima, Hiroshi Tsuneki, Ikuko Kimura. Biol Pharm Bull 2005
31
32

Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye.
F F Behar-Cohen, O Goureau, F D'Hermies, Y Courtois. Invest Ophthalmol Vis Sci 1996
87
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.